PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice
- PMID: 8843627
- DOI: 10.1016/0264-410x(96)82948-3
PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice
Abstract
PspA is a surface exposed virulence factor of S. pneumoniae that can elicit protective immunity to pneumococcal sepsis in mice. It can be released from pneumococci by washing them with a solution containing 2% choline chloride, by growing pneumococci in media containing 1.2% choline chloride, or by growing pneumococci in media in which the choline has been replaced by ethanolamine. Our results indicate that PspA is the major protection-eliciting antigen in each of these preparations. Two injections of < or = 1 microgram of native PspA purified by use of a choline-Sepharose column are highly immunogenic in BALB/c and CBA/N mice, and even in the absence of adjuvant can elicit protection against otherwise fatal sepsis with 100 times the LD50 of S. pneumoniae. Fragments comprising the N-terminal 115 and 245 amino acids of PspA were able to elicit protection but only in the presence of complete Freund's adjuvant (CFA). In the absence of CFA the 245 amino acid fragment was less than 1/100 as immunogenic as native PspA.
Similar articles
-
Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.Infect Immun. 2003 Mar;71(3):1033-41. doi: 10.1128/IAI.71.3.1033-1041.2003. Infect Immun. 2003. PMID: 12595413 Free PMC article.
-
A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence.Infect Immun. 1991 Apr;59(4):1285-9. doi: 10.1128/iai.59.4.1285-1289.1991. Infect Immun. 1991. PMID: 2004810 Free PMC article.
-
PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.Infect Immun. 1991 Jan;59(1):222-8. doi: 10.1128/iai.59.1.222-228.1991. Infect Immun. 1991. PMID: 1987036 Free PMC article.
-
Systemic and mucosal protective immunity to pneumococcal surface protein A.Ann N Y Acad Sci. 1996 Oct 25;797:118-26. doi: 10.1111/j.1749-6632.1996.tb52954.x. Ann N Y Acad Sci. 1996. PMID: 8993356 Review.
-
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).Clin Microbiol Rev. 1998 Oct;11(4):645-57. doi: 10.1128/CMR.11.4.645. Clin Microbiol Rev. 1998. PMID: 9767061 Free PMC article. Review.
Cited by
-
The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine.Infect Immun. 2012 Oct;80(10):3621-33. doi: 10.1128/IAI.00620-12. Epub 2012 Aug 6. Infect Immun. 2012. PMID: 22868499 Free PMC article.
-
Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.Infect Immun. 2000 Oct;68(10):5610-8. doi: 10.1128/IAI.68.10.5610-5618.2000. Infect Immun. 2000. PMID: 10992461 Free PMC article.
-
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment.Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9361-6. doi: 10.1073/pnas.0803801105. Epub 2008 Jul 7. Proc Natl Acad Sci U S A. 2008. PMID: 18607005 Free PMC article.
-
Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.Clin Vaccine Immunol. 2017 Aug 4;24(8):e00118-17. doi: 10.1128/CVI.00118-17. Print 2017 Aug. Clin Vaccine Immunol. 2017. PMID: 28637805 Free PMC article.
-
Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.J Immunol. 2011 Jul 1;187(1):412-23. doi: 10.4049/jimmunol.1100339. Epub 2011 Jun 1. J Immunol. 2011. PMID: 21632711 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources